CNS Pharmaceuticals annual net debt
2018
2019
2020
2022
2023
2024
2025
CNS Pharmaceuticals Net Debt Growth & History (CNSP)
CNS Pharmaceuticals's net debt was −$6.9M for fiscal 2025.
View full CNS Pharmaceuticals company overviewCNS Pharmaceuticals annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$6.9M | −$737,123 | — |
| 2024 | 2024-12-31 | −$6.1M | −$5.9M | — |
| 2023 | 2023-12-31 | −$247,915 | $9.4M | — |
| 2022 | 2022-12-31 | −$9.6M | — | — |
| 2020 | 2020-12-31 | −$13.6M | −$6.3M | — |
| 2019 | 2019-12-31 | −$7.2M | −$7.2M | — |
| 2018 | 2018-12-31 | −$818 | — | — |
CNS Pharmaceuticals quarterly net debt
Q4.18
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | −$2.7M | $10.1M | — |
| Q4 2025 | 2025-12-31 | −$6.9M | — | — |
| Q3 2025 | 2025-09-30 | −$9.8M | — | — |
| Q2 2025 | 2025-06-30 | −$12.0M | — | — |
| Q1 2025 | 2025-03-31 | −$12.8M | — | — |
| Q4 2020 | 2020-12-31 | −$13.6M | −$6.3M | — |
| Q3 2020 | 2020-09-30 | −$1.3M | −$976,989 | — |
| Q2 2020 | 2020-06-30 | −$2.6M | — | — |
| Q1 2020 | 2020-03-31 | −$5.4M | — | — |
| Q4 2019 | 2019-12-31 | −$7.2M | −$7.2M | — |
| Q3 2019 | 2019-09-30 | −$330,109 | — | — |
| Q4 2018 | 2018-12-31 | −$818 | — | — |
CNS Pharmaceuticals net debt trends
Over the last five fiscal years, CNS Pharmaceuticals's net debt increased from −$13.6M to −$6.9M, a change of $6.7M. The latest reported quarter, Q1 2026, shows −$2.7M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CNS Pharmaceuticals source filings ↗